AI MARKET SCANNING

Gyre Therapeutics Inc

📅 Next Catalyst: Nov 05, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -3.33%
MAX GAP RECORD -6.75%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $GYRE
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 05, 2026 Earnings Release 2026-11-05 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 07, 2026 Earnings Release 2026-08-07 (BEFORE OPEN)
+0.16%
May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE)
+1.98%
Mar 12, 2026 Earnings Release 2026-03-12 (BEFORE OPEN)
-5.88%
Nov 07, 2025 Earnings Release 2025-11-07 (BEFORE OPEN)
-0.95%
Aug 11, 2025 Earnings Release 2025-08-11 (AFTER CLOSE)
-5.52%
May 09, 2025 Earnings Release 2025-05-09 (BEFORE OPEN)
-6.75%
Mar 17, 2025 Earnings Release 2025-03-17 (AFTER CLOSE)
-6.35%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.9%
Bullish Gaps (1)
Bearish Gaps (4)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $GYRE

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis). The firm operates through the BC and Gyre segments. The company was founded on March 7, 1997 and is headquartered…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗